Order Article Reprints

Markovic M, Ben-Shabat S, Nagendra Manda J, Abramov-Harpaz K, Regev C, Miller Y, Aponick A, Zimmermann EM, Dahan A. PLA₂-Triggered Activation of Cyclosporine-Phospholipid Prodrug as a Drug Targeting Approach in Inflammatory Bowel Disease Therapy. Pharmaceutics. 2022; 14(3):675. https://doi.org/10.3390/pharmaceutics14030675

Markovic, Milica, Shimon Ben-Shabat, Jagadeesh Nagendra Manda, Karina Abramov-Harpaz, Clil Regev, Yifat Miller, Aaron Aponick, Ellen M. Zimmermann, and Arik Dahan. 2022. "PLA₂-Triggered Activation of Cyclosporine-Phospholipid Prodrug as a Drug Targeting Approach in Inflammatory Bowel Disease Therapy" Pharmaceutics 14, no. 3: 675. https://doi.org/10.3390/pharmaceutics14030675

Markovic, M., Ben-Shabat, S., Nagendra Manda, J., Abramov-Harpaz, K., Regev, C., Miller, Y., Aponick, A., Zimmermann, E. M., & Dahan, A. (2022). PLA₂-Triggered Activation of Cyclosporine-Phospholipid Prodrug as a Drug Targeting Approach in Inflammatory Bowel Disease Therapy. Pharmaceutics, 14(3), 675. https://doi.org/10.3390/pharmaceutics14030675